| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.089 | 0.03 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.03 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |